Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HERODOTUS: Head and Neck cancERs International cOviD-19 collabOraTion

NCT04632173 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT04632173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04632173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HERODOTUS: Head and Neck cancERs International cOviD-19 collabOraTion
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Observational
Overall status
Unknown status
Start date
May 3, 2021
Completion date
December 30, 2022
Enrollment
750 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, head and neck cancer